Coryzalia Boiron 40 tablets
search
  • Coryzalia Boiron 40 tablets

Coryzalia Boiron 40 cps orodispersible


€4.99

Indications: CORYZALIA, orodispersible tablet is a homeopathic medicine traditionally used in the symptomatic treatment of colds and rhinitis.

48 hours
Qty
In stock

In this manual :

1. What is CORYZALIA, orodispersible tablet and what is it used for?

2. What information should I know before taking CORYZALIA, orodispersible tablet ?

3. How do I take CORYZALIA, orodispersible tablet ?

4. What are the possible side effects?

5. How do I keep CORYZALIA, orodispersible tablet ?

6. Additional information.

1. WHAT IS CORYZALIA, orodispersible tablet AND WHAT IS IT USED FOR?

Pharmacotherapeutic class

Not applicable.

Therapeutic indications

CORYZALIA, orodispersible tablet is a homeopathic medicine traditionally used in the symptomatic treatment of colds and rhinitis.

2. WHAT YOU SHOULD KNOW BEFORE TAKING CORYZALIA, orodispersible tablet

List of information needed before taking the medicine

If your doctor has informed you of an intolerance to certain sugars, contact him or her before taking this medicine.

Contraindications

Never use CORYZALIA, orodispersible tablet:

- In children under 18 months of age.

- If you are allergic (hypersensitive) to the active substances or to any of the components contained in CORYZALIA, orodispersible tablet.

Precautions for use; special warnings

Take care with CORYZALIA, orodispersible tablet:

- The use of this medicine is not recommended in patients with galactose intolerance, Lapp lactase deficiency or glucose or galactose malabsorption syndrome (rare hereditary diseases).

Interactions with other drugs

Taking other medications:

Talk to your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Interactions with food and drink

Food and drink

This medicine should be taken with meals.

Interactions with herbal products or alternative therapies

Not applicable.

Use during pregnancy and breastfeeding

Pregnancy and breastfeeding

Ask your doctor or pharmacist for advice before taking any medicine.

Sportsmen

Not applicable.

Effects on ability to drive and use machines

Driving and use of machinery :

Not applicable.

List of excipients with a known effect

Important information about some ingredients of CORYZALIA, orodispersible tablet:

This medicine contains lactose.

3. HOW TO TAKE CORYZALIA, orodispersible tablet

Instructions for proper use

Not applicable.

Dosage, Method and/or route(s) of administration, Frequency of administration and Duration of treatment

Dosage

For adults and children over 18 months of age only.

Adults and children over 18 months: 1 tablet 6 to 8 times daily.

For children aged 18 months to 6 years, the tablet should be dissolved in a little water.

Mode and route of administration

Sublingual route.

Frequency of administration

Spacing out the doses as soon as they improve and stop taking them as soon as the symptoms disappear.

Duration of treatment

The duration of treatment should not exceed one week.

Symptoms and instructions in case of overdose

If you have taken more CORYZALIA, orodispersible tablet than you should have:

Consult your doctor or pharmacist.

Instructions if you miss one or more doses

If you forget to take CORYZALIA, orodispersible tablet:

Do not take a double dose to make up for the dose you forgot to take.

Risk of withdrawal syndrome

Not applicable.

4. WHAT ARE THE POSSIBLE SIDE EFFECTS?

Description of side effects

Like all medicines, CORYZALIA, orodispersible tablet is likely to have side effects, although not everyone is subject to them.

If you notice any side effects not listed in this leaflet, or if any side effects become serious, please tell your doctor or pharmacist.

5. HOW TO CONSERVE CORYZALIA, orodispersible tablet

Keep out of the reach and sight of children.

Expiry date

Do not use CORYZALIA, orodispersible tablet after the expiry date on the box.

Storage conditions

Store at a temperature not exceeding 30°C.

If necessary, warnings against certain visible signs of deterioration

Medicines should not be disposed of down the drain or in the household garbage. Ask your pharmacist what to do with unused medicines. This will help protect the environment.

6. ADDITIONAL INFORMATION

Full list of active ingredients and excipients

What does CORYZALIA orodispersible tablet contain?

The active ingredients are :

ALLIUM CEPA 3CH ......................................................................................................................... 0.5 mg

BELLADONNA 3CH ......................................................................................................................... 0.5 mg

KALIUM BICHROMICUM 3CH ............................................................................................................ 0.5 mg

GELSEMIUM 3CH............................................................................................................................. 0.5 mg

SABADILLA 3CH............................................................................................................................... 0.5 mg

for an orodispersible tablet of 250 mg.

The other components are:

Lactose, croscarmellose sodium, magnesium stearate.

Pharmaceutical form and content

What is CORYZALIA, orodispersible tablet and what does it contain?

CORYZALIA, orodispersible tablet is presented in the form of orodispersible tablets. They are packaged in a box containing 40 tablets.

Name and address of the marketing authorisation holder and of the manufacturing authorisation holder responsible for batch release, if different

Holder

BOIRON

20 rue de la liberation

69110 sainte foy les lyon

FRANCE

Operator

BOIRON

20 rue de la liberation

69110 sainte foy les lyon

FRANCE

Manufacturer

BOIRON

2 avenue de l'ouest lyonnais

69510 messimy

FRANCE

Names of the medicinal product in the Member States of the European Economic Area

Not applicable.

Date of approval of the package leaflet

The last date on which this package insert was approved was {date}.

MA under exceptional circumstances

Not applicable.

Internet information

Detailed information on this medicinal product is available on the ANSM website (France).

Information for healthcare professionals

Not applicable.

Other

Not applicable.

3400922468860

Specific References

chat Comments (0)
No customer reviews for the moment.